depressive disorder Diabetes Mellitus hyperglyceamia
Conditions
Interventions
None listed
Sponsors
Maaslandziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Diabetes Mellitus Starting, discontinuing , switching or dose change with antidepressant
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary study parameter is starting, swithing or discontinuing a antidepressant or having a dose change with an antidepressant. The primary outcome is defined as changes in insulin and/or oral antidiabetic use in the period of 182 days after intervention compared to the period of 30 days prior to intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secundary study outcomes are changes in glucose glucose, HbA1, LDL, HDL and triglycerides measured during the first diabetes laboratory investigation after index date compared with the diabetes laboratory investigation prior to index date. | — |
Countries
Netherlands
Outcome results
None listed